What You Should Know:
- Techmed startup illumicell AI, founded by a team of Harvard-trained physician Michel Bielecki, former McKinsey consultant Jeyla Sadikova, and rocket engineer Loup Cordey, has secured $2M in pre-seed funding. The funding round was supported by a combination of healthcare operators, clinicians, and early-stage funds, including life science investors KOFA Healthcare, Harvard Phoenix Venture Fund, and MedTechSyndicates
- The company aims to transform fluid-based
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Flatiron Health and Massive Bio Partner to Improve Clinical Trial Enrollment
What You Should Know:
- Flatiron Health, a healthtech company focused on transforming clinical research through technology that integrates research into everyday care, has announced a strategic partnership with Massive Bio, a global leader in using artificial intelligence to streamline patient identification and recruitment for clinical trials.
- The partnership aims to expand patient identification capabilities and improve clinical trial enrollment across the U.S.
Enhance
Read More
Simplifying Clinical Trials: Addressing Technology Challenges for Site Teams
In recent years, clinical research and development stakeholders have put tremendous effort into improving patient-centered clinical trials, where patients feel valued as partners in the processes and approaches to care that impact their health. Clinical trial sponsors are keenly aware that, to do so, the use of advanced clinical technologies, including decentralized solutions, has been necessary to improve patient experience and accelerate drug development. But as sponsors implement multiple
Read More
How 3D Modeling is Transforming Medical Imaging and Diagnosis
In the 21st century, we are fortunate to benefit from perpetual advances in medicine. Researchers continue to discover new procedures and treatments, and those advances often rely on technology. Improvements in hardware, internet speeds, interconnected devices, and artificial intelligence all contribute to higher efficiency, personalization, and accessibility in treatments.
Technologies such as advanced imaging and modeling (AIM), augmented reality/virtual reality (AR/VR), 3D printers,
Read More
Pharma R&D Returns Surge in 2024, Driven by GLP-1 Therapies, Despite Rising Costs
What You Should Know:
- The pharmaceutical research and development (R&D) sector is experiencing a significant upswing, with projected returns on investment climbing to 5.9% in 2024, according to a new report by Deloitte.
- This surge, building on 2023’s 4.1%, is largely attributed to the success of GLP-1 therapies, showcasing the lucrative potential of addressing substantial unmet medical needs. However, this positive trend is juxtaposed with rising drug development costs
Read More
Operation Warp Speed Leader Tapped as Panther Life Sciences’ New R&D Chief
What You Should Know:
- Panther Life Sciences, a life sciences company specializing in skin-based treatments using microarray patches (MAPs), has announced the appointment of Dr. Matthew Hepburn as Executive Vice President of Research and Development.
- Dr. Hepburn will be instrumental in driving Panther’s strategic vision to commercialize its patented MAP technology, with a focus on delivering the first commercial product to market within the next two years.
- In his new
Read More
Dassault Systèmes Invests in Click Therapeutics to Advance Digital Therapeutics
What You Should Know:
- Dassault Systèmes has announced a strategic investment in Click Therapeutics, a pioneering company in prescription digital therapeutics (PDTs) and software-enhanced (SE) drug therapies. This investment signifies Dassault Systèmes' commitment to transforming the patient experience within the life sciences and healthcare sectors through comprehensive, end-to-end technology solutions.
The investment builds upon the existing collaboration between Dassault
Read More
InformedDNA Acquires Coriell Life Sciences, Expanding Precision Health Capabilities
What You Should Know:
- InformedDNA®, a precision health company focused on revolutionizing the application of genomic insights, has announced its acquisition of Coriell Life Sciences, a provider of pharmacogenomic services and clinical decision support. Financial details of the acquisition were not disclosed.
- The strategic acquisition significantly expands InformedDNA's capabilities, offering patients, providers, and payers broader access to genetic insights for more
Read More
Flatiron Health, NRG Oncology to Streamline Cancer Clinical Trials with EHR-to-EDC
What You Should Know:
- Flatiron Health, a healthtech company focused on revolutionizing clinical research through technology integration, has announced a collaboration with NRG Oncology, a clinical research consortium within the National Cancer Institute's (NCI) National Clinical Trials Network (NCTN).
- The partnership aims to deploy Flatiron’s Clinical Pipe™ in a multicenter NRG clinical trial, streamlining data entry and accelerating study timelines.
Supporting
Read More
Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases
What You Should Know:
- Helix, a leader in population genomics and precision health, is announcing a new comprehensive clinico-genomic virtual registry of autoimmune disease patients.
- Consisting of over 23,000 individuals with conditions such as Lupus, Rheumatoid Arthritis (RA), Psoriasis, Multiple Sclerosis (MS), Hashimoto's disease, Crohn's and many more, it's one of the largest autoimmune cohorts in the world.
Helix Expands Autoimmune Research Capabilities with
Read More
